These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 27930582

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
    Karava V, Benzouid C, Hogan J, Dossier C, Denjean AP, Deschênes G.
    Pediatr Nephrol; 2018 Sep; 33(9):1513-1521. PubMed ID: 29774463
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
    Kim H, Koh J, Park SK, Oh KH, Kim YH, Kim Y, Ahn C, Oh YK.
    Nephrology (Carlton); 2019 Apr; 24(4):422-429. PubMed ID: 29797773
    [Abstract] [Full Text] [Related]

  • 27. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW, HALT-PKD Study.
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [Abstract] [Full Text] [Related]

  • 28. Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
    Lai S, Mittherhofer AP, Cianci R, Riviello L, Vocaturi M, Mastroluca D, Ciccariello M, Von Heland M, Ricciuti GP, Salciccia S, Mazzaferro S.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2734-2743. PubMed ID: 31002123
    [Abstract] [Full Text] [Related]

  • 29. [Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].
    Sans Atxer L, Roca-Cusachs A, Torra R, Calero F, Arias P, Ballarin J, Fernández-Llama P.
    Nefrologia; 2010 Apr; 30(5):567-72. PubMed ID: 20882096
    [Abstract] [Full Text] [Related]

  • 30. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
    Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW.
    Clin J Am Soc Nephrol; 2014 May; 9(5):889-96. PubMed ID: 24721893
    [Abstract] [Full Text] [Related]

  • 31. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M, Inci A.
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [Abstract] [Full Text] [Related]

  • 32. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ, CRISP Investigators.
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension.
    Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW.
    Kidney Int; 2008 Nov; 74(9):1192-6. PubMed ID: 18716604
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.
    Valero FA, Martinez-Vea A, Bardají A, Gutierrez C, Garcia C, Richart C, Oliver JA.
    J Am Soc Nephrol; 1999 May; 10(5):1020-6. PubMed ID: 10232688
    [Abstract] [Full Text] [Related]

  • 39. Blood pressure response to exercise in unaffected relatives of autosomal dominant polycystic kidney disease patients: an observational study.
    Yenigun EC, Turgut D, Cevher SK, Yucel C, Aypak C, Dede F.
    Int Urol Nephrol; 2023 Sep; 55(9):2313-2319. PubMed ID: 36872421
    [Abstract] [Full Text] [Related]

  • 40. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
    Pietrzak-Nowacka M, Safranow K, Czechowska M, Dutkiewicz G, Kornacewicz-Jach Z, Ciechanowski K.
    Kidney Blood Press Res; 2012 Sep; 36(1):301-9. PubMed ID: 23235185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.